Shenzhen Mindray Financials
| 300760 Stock | 272.01 2.99 1.09% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 6.7 B | 12.9 B |
|
|
Shenzhen | Select Account or Indicator |
Understanding current and past Shenzhen Mindray Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Shenzhen Mindray's financial statements are interrelated, with each one affecting the others. For example, an increase in Shenzhen Mindray's assets may result in an increase in income on the income statement.
Please note, the presentation of Shenzhen Mindray's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Shenzhen Mindray's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Shenzhen Mindray's management manipulating its earnings.
Shenzhen Mindray Stock Summary
Shenzhen Mindray competes with Industrial, China Construction, Bank of China, Agricultural Bank, and PetroChina. Shenzhen Mindray is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE100003G67 |
| Business Address | Mindray Building, Shenzhen, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.mindray.com |
| Phone | 86 755 8188 8997 |
You should never invest in Shenzhen Mindray without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Shenzhen Stock, because this is throwing your money away. Analyzing the key information contained in Shenzhen Mindray's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Shenzhen Mindray Key Financial Ratios
Shenzhen Mindray's financial ratios allow both analysts and investors to convert raw data from Shenzhen Mindray's financial statements into concise, actionable information that can be used to evaluate the performance of Shenzhen Mindray over time and compare it to other companies across industries.| Revenue | 34.93 B | ||||
| Gross Profit | 19.48 B | ||||
| EBITDA | 14.41 B | ||||
| Net Income | 11.58 B | ||||
| Total Asset | 47.94 B |
Shenzhen Mindray Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 25.6B | 33.3B | 38.1B | 46.7B | 47.9B | 30.9B | |
| Other Current Liab | 2.4B | 4.7B | 3.8B | 7.2B | 365.3M | 347.0M | |
| Other Liab | 2.0B | 1.8B | 2.4B | 2.8B | 3.3B | 1.9B | |
| Net Tangible Assets | 16.3B | 20.9B | 20.7B | 25.6B | 29.4B | 14.8B | |
| Retained Earnings | 9.2B | 14.0B | 19.0B | 24.4B | 24.7B | 13.0B | |
| Accounts Payable | 1.2B | 1.5B | 2.3B | 2.3B | 2.7B | 1.6B | |
| Cash | 14.3B | 15.9B | 15.4B | 23.2B | 18.8B | 13.5B | |
| Other Assets | 991.0M | 1.2B | 1.3B | 3.4B | 3.9B | 4.1B | |
| Net Receivables | 2.0B | 1.4B | 1.9B | 2.7B | 3.3B | 2.1B | |
| Good Will | 1.3B | 1.2B | 4.2B | 4.4B | 5.1B | 2.6B | |
| Inventory | 2.3B | 3.6B | 3.7B | 4.0B | 4.0B | 2.8B | |
| Other Current Assets | 200.5M | 183.3M | 270.7M | 585.3M | 349.7M | 263.1M | |
| Total Liab | 7.0B | 10.0B | 11.1B | 14.7B | 14.6B | 10.5B | |
| Total Current Assets | 18.7B | 21.6B | 21.3B | 30.6B | 26.9B | 19.2B | |
| Intangible Assets | 1.1B | 1.3B | 2.2B | 2.3B | 2.6B | 1.6B | |
| Net Invested Capital | 18.6B | 23.3B | 27.0B | 32.0B | 33.1B | 24.7B | |
| Net Working Capital | 13.7B | 13.4B | 12.7B | 18.8B | 16.8B | 13.9B |
Shenzhen Mindray Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Shenzhen Mindray Bio. It measures of how well Shenzhen is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Shenzhen Mindray brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Shenzhen had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Shenzhen Mindray has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (706.7M) | (1.4B) | (133.6M) | (523.0M) | (201.4M) | (211.5M) | |
| Change In Cash | 2.7B | 1.6B | (589.8M) | 3.8B | (305.2M) | (290.0M) | |
| Depreciation | 394.3M | 472.1M | 666.2M | 885.1M | 1.0B | 547.4M | |
| Dividends Paid | 1.2B | 1.8B | 3.0B | 4.2B | 10.7B | 11.2B | |
| Capital Expenditures | 776.9M | 1.2B | 1.4B | 1.9B | 2.7B | 2.8B | |
| Net Income | 4.7B | 6.7B | 8.0B | 9.6B | 11.6B | 6.0B | |
| Change To Netincome | 164.3M | 407.3M | (107.9M) | (112.4M) | (101.2M) | (96.1M) | |
| End Period Cash Flow | 14.1B | 15.7B | 15.1B | 19.0B | 18.7B | 14.2B | |
| Free Cash Flow | 3.9B | 7.7B | 7.6B | 10.2B | 8.4B | 6.9B | |
| Other Non Cash Items | 4.3M | 215.6M | (210.3M) | (214.3M) | (188.0M) | (178.6M) |
Shenzhen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shenzhen Mindray's current stock value. Our valuation model uses many indicators to compare Shenzhen Mindray value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shenzhen Mindray competition to find correlations between indicators driving Shenzhen Mindray's intrinsic value. More Info.Shenzhen Mindray Bio Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.50 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Shenzhen Mindray Bio Medical is roughly 2.02 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Shenzhen Mindray by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shenzhen Mindray's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Shenzhen Mindray Bio Systematic Risk
Shenzhen Mindray's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Shenzhen Mindray volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Shenzhen Mindray Bio correlated with the market. If Beta is less than 0 Shenzhen Mindray generally moves in the opposite direction as compared to the market. If Shenzhen Mindray Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Shenzhen Mindray Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Shenzhen Mindray is generally in the same direction as the market. If Beta > 1 Shenzhen Mindray moves generally in the same direction as, but more than the movement of the benchmark.
Shenzhen Mindray Bio Medical Total Assets Over Time
Shenzhen Mindray November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Shenzhen Mindray help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Shenzhen Mindray Bio Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Shenzhen Mindray Bio Medical based on widely used predictive technical indicators. In general, we focus on analyzing Shenzhen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Shenzhen Mindray's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.78 | |||
| Information Ratio | 0.0203 | |||
| Maximum Drawdown | 19.76 | |||
| Value At Risk | (4.56) | |||
| Potential Upside | 9.9 |
Complementary Tools for Shenzhen Stock analysis
When running Shenzhen Mindray's price analysis, check to measure Shenzhen Mindray's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shenzhen Mindray is operating at the current time. Most of Shenzhen Mindray's value examination focuses on studying past and present price action to predict the probability of Shenzhen Mindray's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shenzhen Mindray's price. Additionally, you may evaluate how the addition of Shenzhen Mindray to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |